Xenon Pharmaceuticals Inc (XENE)

May 02, 2026

XENON PHARMACEUTICALS INC (NASDAQ:XENE) Breakout Setup Combines 9/10 Technical Strength with 9/10 Consolidation Quality - ChartMill

May 02, 2026

May 01, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 01, 2026

May 01, 2026

Seven new Xenon hires get stock awards priced at $56.04 - Stock Titan

May 01, 2026

May 01, 2026

Jennison Associates LLC Boosts Stock Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

May 01, 2026

May 01, 2026

Pictet Asset Management Holding SA Cuts Position in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

May 01, 2026

Apr 30, 2026

Xenon to Report Q1 2026 Financial Results on May 7, 2026 - The Manila Times

Apr 30, 2026

Apr 30, 2026

May 7 after the bell: Xenon to give Q1 update, host webcast - Stock Titan

Apr 30, 2026

Apr 30, 2026

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - MarketBeat

Apr 30, 2026

Apr 28, 2026

Xenon spikes, Theravance sinks after phase III readouts in March - BioWorld News

Apr 28, 2026

Apr 26, 2026

Xenon Pharmaceuticals Highlights Strong Phase III Azetukalner Data, Q3 NDA Plans at Bloom Burton Conference - MarketBeat

Apr 26, 2026

Apr 25, 2026

XENE Price Today: Xenon Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 25, 2026

Apr 24, 2026

Xenon Pharmaceuticals Reports Positive Phase 3 Azetukalner Results - HarianBasis.co

Apr 24, 2026

Apr 24, 2026

Peregrine Capital Management LLC Invests $7.84 Million in Xenon Pharmaceuticals Inc. $XENE - MarketBeat

Apr 24, 2026

Apr 23, 2026

Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here - Yahoo Finance

Apr 23, 2026

Apr 22, 2026

Xenon's Phase 3 Supports A 'Buy' Despite Its Premium (NASDAQ:XENE) - Seeking Alpha

Apr 22, 2026

Apr 22, 2026

[ARS] Xenon Pharmaceuticals Inc. SEC Filing - Stock Titan

Apr 22, 2026

Apr 22, 2026

Xenon Pharmaceuticals (XENE) 2026 proxy details board elections and new equity plan - Stock Titan

Apr 22, 2026

Apr 21, 2026

Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), Biogen (BIIB) - The Globe and Mail

Apr 21, 2026

Apr 20, 2026

Needham Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $80 - Moomoo

Apr 20, 2026

Apr 20, 2026

RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - MSN

Apr 20, 2026

Apr 20, 2026

Stifel sees Xenon Pharmaceuticals stock reaching $2B in peak sales - Investing.com

Apr 20, 2026

Apr 20, 2026

Xenon Pharmaceuticals (XENE) Reports Positive Phase 3 Study Resu - GuruFocus

Apr 20, 2026

Apr 19, 2026

Xenon Pharma’s azetukalner shows 53% seizure reduction in trial By Investing.com - Investing.com South Africa

Apr 19, 2026

Apr 19, 2026

Xenon presents positive epilepsy drug trial data at AAN meeting - Investing.com

Apr 19, 2026

Apr 19, 2026

Xenon presents positive epilepsy drug trial data at AAN meeting By Investing.com - Investing.com Canada

Apr 19, 2026

Apr 19, 2026

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting - The Manila Times

Apr 19, 2026

Apr 19, 2026

Xenon Pharmaceuticals Reports Positive Phase 3 X-TOLE2 Study Results for Azetukalner in Focal Onset Seizures at AAN 2026 - Quiver Quantitative

Apr 19, 2026

Apr 19, 2026

Xenon Pharma’s azetukalner shows 53% seizure reduction in trial - Investing.com UK

Apr 19, 2026

Apr 19, 2026

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results - GlobeNewswire

Apr 19, 2026

Apr 16, 2026

Xenon to Present at Upcoming Investor Conferences - Sahm

Apr 16, 2026

Apr 16, 2026

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE) - MarketBeat

Apr 16, 2026

Apr 15, 2026

Xenon to Spotlight Neurology Pipeline at Series of 2026 Investor Conferences - TipRanks

Apr 15, 2026

Apr 14, 2026

Xenon Expands 2025 Inducement Equity Incentive Plan - The Globe and Mail

Apr 14, 2026

Apr 14, 2026

Xenon Pharmaceuticals Amends 2025 Inducement Equity Incentive Plan for Nasdaq Compliance and Employee Attraction 10 - Minichart

Apr 14, 2026

Apr 13, 2026

Xenon Pharmaceuticals (XENE) boosts 2025 inducement equity plan share reserve - Stock Titan

Apr 13, 2026

Apr 11, 2026

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Apr 11, 2026

Apr 09, 2026

Certain Restricted Stock Units of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026. - marketscreener.com

Apr 09, 2026

Apr 09, 2026

Certain Stock Options of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026. - marketscreener.com

Apr 09, 2026

Apr 09, 2026

Certain Common Shares of Xenon Pharmaceuticals Inc. are subject to a Lock-Up Agreement Ending on 10-APR-2026. - marketscreener.com

Apr 09, 2026

Apr 09, 2026

Published on: 2026-04-09 12:46:57 - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Xenon Pharmaceuticals to present azetukalner epilepsy data at AAN By Investing.com - Investing.com Australia

Apr 08, 2026

Apr 07, 2026

Xenon Pharmaceuticals to present azetukalner epilepsy data at AAN - Investing.com

Apr 07, 2026